EnglishFrenchGermanItalianSpanish

NeuMoDx Molecular Systems

DESIGNING AND DEVELOPING REVOLUTIONARY MOLECULAR DIAGNOSTIC SOLUTIONS

Our patented, “sample to result” platform offers market-leading ease of use, true continuous random-access and rapid turnaround time while achieving optimal operational and clinical performance for our customers and their patients.

POWERFUL. SIMPLE. DIAGNOSTICS™

The NeuMoDx™ Molecular, a QIAGEN company are a family of scalable platforms that fully integrate the entire molecular diagnostic process from “sample to result”. The NeuMoDx™ 288 and the NeuMoDx™ 96 Molecular Systems are fully automated, continuous random-access analyzers utilizing our proprietary NeuDry™ reagent technology, which integrates magnetic particle affinity capture and real time Polymerase Chain Reaction (PCR) chemistry in a multi-sample microfluidic cartridge. This technology, combined with a platform, uniquely incorporates robotics and microfluidics resulting in higher throughput, improved performance and increased efficiency by eliminating the waste associated with technologies that require reconstitution of lyophilized reagents.

NeuMoDx has a strong IP portfolio that includes greater than 20 US patents along with corresponding foreign patents and applications.

OUR VISION

Create a scalable family of molecular testing platforms easily integrated into the molecular diagnostic process. Enable laboratory professionals to operate more efficiently and cost-effectively, thereby increasing the use of molecular diagnostic testing by medical providers to better identify and treat disease early.

Our Solutions
NEWSROOM

DISCOVER WHAT WE ARE DOING

READ ALL ABOUT IT
Join Us

At NeuMoDx™, we work together with the common goal of designing and developing revolutionary molecular diagnostic solutions for hospital and clinical reference laboratories. We are always looking for caring, energetic individuals to join our team.

Careers

IMPORTANT ANNOUNCEMENT

We are excited to announce that QIAGEN has acquired all shares of NeuMoDx Molecular, Inc. The addition of NeuMoDx’s medium- and high-throughput molecular systems further expands QIAGEN’s portfolio of molecular diagnostics instruments, bolstering our leadership in automated molecular testing. We are proud to welcome NeuMoDx to our family of PCR solutions that make improvements in life possible.

To learn more, click here.